The CORRONA database.
作者信息
Kremer J
机构信息
Center for Rheumatology, Albany Medical College, 1367 Washington Avenue, Albany, NY 12203, USA.
出版信息
Ann Rheum Dis. 2005 Nov;64 Suppl 4(Suppl 4):iv37-41. doi: 10.1136/ard.2005.043497.
Abstract
摘要
相似文献
1
The CORRONA database.CORRONA数据库。
Ann Rheum Dis. 2005 Nov;64 Suppl 4(Suppl 4):iv37-41. doi: 10.1136/ard.2005.043497.
2
The CORRONA database.CORRONA数据库。
Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S172-7.
3
"Design characteristics of the CORRONA CERTAIN study: a comparative effectiveness study of biologic agents for rheumatoid arthritis patients".CORRONA CERTAIN研究的设计特点：类风湿关节炎患者生物制剂的比较疗效研究
BMC Musculoskelet Disord. 2014 Apr 1;15:113. doi: 10.1186/1471-2474-15-113.
4
5
Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research.将一个去识别化的美国类风湿关节炎登记处与行政数据相链接，以促进比较效果研究。
Arthritis Care Res (Hoboken). 2014 Dec;66(12):1790-8. doi: 10.1002/acr.22377.
6
[National database documentation for collecting, controlling and quality assurance of new therapies in rheumatoid arthritis].
Z Rheumatol. 2001 Dec;60(6):469-72. doi: 10.1007/s003930170014.
7
The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the road.2008年美国风湿病学会关于非生物和生物改善病情抗风湿药在类风湿关节炎中应用的推荐意见：实际应用情况
Arthritis Rheum. 2008 Jun 15;59(6):757-9. doi: 10.1002/art.23723.
8
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.2008年美国风湿病学会关于使用改善病情抗风湿药和生物制剂治疗类风湿关节炎的建议的2012年更新版。
Arthritis Care Res (Hoboken). 2012 May;64(5):625-39. doi: 10.1002/acr.21641.
9
Incidence and Predictors of Biological Antirheumatic Drug Discontinuation Attempts among Patients with Rheumatoid Arthritis in Remission: A CORRONA and NinJa Collaborative Cohort Study.缓解期类风湿关节炎患者尝试停用生物抗风湿药物的发生率及预测因素：一项CORRONA和NinJa合作队列研究
J Rheumatol. 2015 Dec;42(12):2238-46. doi: 10.3899/jrheum.150240. Epub 2015 Nov 1.
10
Non-overlapping American College of Rheumatology response rates: a better way to report response in rheumatoid arthritis clinical trials.美国风湿病学会反应率无重叠：类风湿关节炎临床试验中报告反应的更好方法。
Arthritis Rheum. 2010 Dec;62(12):3524-7. doi: 10.1002/art.27711.
引用本文的文献
1
Effectiveness of tofacitinib versus tumor necrosis factor inhibitors and in those receiving tofacitinib as different lines of therapy in patients with rheumatoid arthritis: results from the United States CorEvitas Rheumatoid Arthritis Registry.托法替布与肿瘤坏死因子抑制剂相比的有效性，以及类风湿关节炎患者接受不同治疗线托法替布治疗的有效性：来自美国CorEvitas类风湿关节炎注册研究的结果
Clin Rheumatol. 2025 Feb;44(2):635-648. doi: 10.1007/s10067-024-07245-3. Epub 2024 Dec 20.
2
Patterns in the Sequential Treatment of Patients With Rheumatoid Arthritis Starting a Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drug: 10-Year Experience From a US-Based Registry.开始使用生物制剂或靶向合成改善病情抗风湿药物的类风湿关节炎患者序贯治疗模式：来自美国一个注册机构的10年经验
ACR Open Rheumatol. 2024 Jan;6(1):5-13. doi: 10.1002/acr2.11621. Epub 2023 Oct 26.
3
Anti-citrullinated protein antibody profiles predict changes in disease activity in patients with rheumatoid arthritis initiating biologics.抗瓜氨酸化蛋白抗体谱可预测起始生物制剂治疗的类风湿关节炎患者疾病活动度的变化。
Rheumatology (Oxford). 2024 Feb 1;63(2):542-550. doi: 10.1093/rheumatology/kead260.
4
The effect of targeted rheumatoid arthritis therapeutics on systemic inflammation and anemia: analysis of data from the CorEvitas RA registry.靶向类风湿关节炎治疗对全身炎症和贫血的影响：来自 CorEvitas RA 注册研究的数据分析。
Arthritis Res Ther. 2022 Dec 21;24(1):276. doi: 10.1186/s13075-022-02955-y.
5
TNFi Cycling Versus Changing Mechanism of Action in TNFi-Experienced Patients: Result of the Corrona CERTAIN Comparative Effectiveness Study.肿瘤坏死因子抑制剂（TNFi）循环使用与TNFi治疗经验丰富患者的作用机制改变：Corrona CERTAIN比较疗效研究结果
ACR Open Rheumatol. 2022 Jan;4(1):65-73. doi: 10.1002/acr2.11337. Epub 2021 Nov 5.
6
The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy.疾病修正抗风湿药物的治疗顺序：托珠单抗单药治疗的途径和预测因素。
Arthritis Res Ther. 2021 Jan 14;23(1):26. doi: 10.1186/s13075-020-02408-4.
7
Long-term remission and biologic persistence rates: 12-year real-world data.长期缓解率和生物制剂持续率：12年真实世界数据。
Arthritis Res Ther. 2021 Jan 13;23(1):25. doi: 10.1186/s13075-020-02380-z.
8
Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study.比较类风湿关节炎患者一线肿瘤坏死因子抑制剂与非肿瘤坏死因子抑制剂生物制剂和靶向合成药物的疗效：来自一项大型美国注册研究的结果。
Ann Rheum Dis. 2021 Jan;80(1):96-102. doi: 10.1136/annrheumdis-2020-217209. Epub 2020 Jul 21.
9
Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis.托法替布与肿瘤坏死因子抑制剂作为单药疗法和联合疗法治疗类风湿关节炎的真实世界比较疗效
Rheumatol Ther. 2019 Nov 9;6(4):573-86. doi: 10.1007/s40744-019-00177-4.
10
Can machine learning predict responses to TNF inhibitors?机器学习能预测对肿瘤坏死因子抑制剂的反应吗？
Nat Rev Rheumatol. 2019 Dec;15(12):702-704. doi: 10.1038/s41584-019-0320-9.
本文引用的文献
1
Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists.心血管合并症及阿司匹林联合使用对风湿病学家选择环氧化酶抑制剂的影响。
Arthritis Rheum. 2005 Feb 15;53(1):12-7. doi: 10.1002/art.20905.
2
Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption.炎症性多关节炎发生的饮食风险因素：红肉高摄入量作用的证据。
Arthritis Rheum. 2004 Dec;50(12):3804-12. doi: 10.1002/art.20731.
3
A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis.吸烟与人类白细胞抗原DR（HLA-DR）中的共享表位基因之间的基因-环境相互作用会导致血清阳性类风湿性关节炎的高风险。
Arthritis Rheum. 2004 Oct;50(10):3085-92. doi: 10.1002/art.20553.
4
Sensitivity to change of the health assessment questionnaire (HAQ) and other clinical and health status measures in rheumatoid arthritis: results of short-term clinical trials and observational studies versus long-term observational studies.类风湿关节炎中健康评估问卷（HAQ）及其他临床和健康状况指标对变化的敏感性：短期临床试验和观察性研究与长期观察性研究的结果
Arthritis Care Res. 1992 Sep;5(3):130-6. doi: 10.1002/art.1790050304.
Zotero 插件